KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Current Leases (2019 - 2025)

Opko Health's Current Leases history spans 7 years, with the latest figure at $1.7 million for Q4 2025.

  • For Q4 2025, Current Leases fell 86.64% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $1.7 million, down 86.64%, while the annual FY2025 figure was $1.7 million, 86.64% down from the prior year.
  • Current Leases reached $1.7 million in Q4 2025 per OPK's latest filing, up from $1.5 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $12.6 million in Q4 2024 to a low of $1.5 million in Q3 2025.
  • Average Current Leases over 5 years is $7.6 million, with a median of $10.2 million recorded in 2021.
  • Peak YoY movement for Current Leases: skyrocketed 347.44% in 2024, then tumbled 86.64% in 2025.
  • A 5-year view of Current Leases shows it stood at $11.6 million in 2021, then rose by 0.03% to $11.6 million in 2022, then tumbled by 75.69% to $2.8 million in 2023, then skyrocketed by 347.44% to $12.6 million in 2024, then crashed by 86.64% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Current Leases are $1.7 million (Q4 2025), $1.5 million (Q3 2025), and $1.6 million (Q2 2025).